510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K991079Substantially Equivalent

Accusign Bzo, Biosign Bzo, Status Bzo

Princeton BioMeditech Corp., Monmouth Junction NJ / Special, Substantially Equivalent
FDA source (opens on fda.gov)

K991079 is the FDA 510(k) clearance record for ACCUSIGN BZO, BIOSIGN BZO, STATUS BZO, a class II device, cleared for Princeton BioMeditech Corp. on under FDA product code JXM (Enzyme Immunoassay, Benzodiazepine). FDA records list 72 510(k) clearances for Princeton BioMeditech Corp., from to . As of , FDA records show no recalls naming K991079.

Clearance record

Decision date
Received
(20 days to decision)
Product code
JXM Enzyme Immunoassay, Benzodiazepine
Regulation
21 CFR 862.3170
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Princeton BioMeditech Corp. 4242 U.S. Rte. 1, Monmouth Junction NJ
510(k) summary
Statement
Third party review
No

Clearances, product code JXM

Trailing 12 months

FDA records hold no clearances under product code JXM in the trailing twelve months.

FDA records show no clearances under product code JXM in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JXM, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260